Matthew J. Elder

Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

Stefanie Mullins, John P. Vasilakos, Katharina Deschler et al. · Journal for ImmunoTherapy of Cancer · 2019 · 204 citations · Full text

Life Sciences, Immunology, Oncology +17

Developing in vitro expanded CD45RA⁺regulatory T cells as an adoptive cell therapy for Crohn's disease

James B. Canavan, Cristiano Scottà, Anna Vossenkämper et al. · Gut · 2015 · 194 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells

Simon J. Dovedi, Matthew J. Elder, Chunning Yang et al. · Cancer Discovery · 2021 · 180 citations

Life Sciences, Immunology, Oncology +17

β-Glucan Size Controls Dectin-1-Mediated Immune Responses in Human Dendritic Cells by Regulating IL-1β Production

Matthew J. Elder, Steve J. Webster, Ronnie Chee et al. · Frontiers in Immunology · 2017 · 103 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infection

Steve J. Webster, Sven Brode, Lou Ellis et al. · PLoS Pathogens · 2017 · 81 citations · Full text

Life Sciences, Immunology, Microbiology +17